Ravulizumab,Eculizumab
alexion pharma
[]
research found that ravulizumab has a more convenient dosing schedule than eculizumab for patients with neuromyelitis optica spectrum disorder. #aanam nyu langone neurology chair dr. steven galetta recently spoke with about this result: 
The latest clinical news and research from experts at @nyulangone. Ranked #2 Best Medical School and #3 Best Hospital in the nation by U.S. News & World Report.